» Articles » PMID: 12566294

Disparity Between DNA Base Excision Repair in Yeast and Mammals: Translational Implications

Overview
Journal Cancer Res
Specialty Oncology
Date 2003 Feb 5
PMID 12566294
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

One approach to the effective treatment of cancer requires the continued development of novel chemotherapeutic agents to kill tumor cells. Additionally, an element of cancer research has been devoted to understanding DNA repair pathways in hopes of defining the factors that confer resistance to anticancer drugs and developing strategies for modulating repair capacity as a means of overcoming resistance or enhancing sensitivity to cancer treatments. Historically, yeast, particularly Saccharomyces cerevisiae, has been used as a model system for DNA repair analyses. Additionally, it has been used to evaluate drug efficacy and selectivity, and to identify new targets for antitumor drugs. The usefulness of yeast for these types of analyses has been primarily because of it being considered to have well-conserved DNA repair processes among eukaryotes. However, as more information has accumulated in mammalian DNA repair, and particularly in DNA base excision repair (BER), a number of striking differences have emerged between yeast and mammalian (human) repair processes. The BER pathway is essential for the repair of damaged DNA induced by oxidizing and alkylating agents, which are the majority of chemotherapeutic drugs used currently in the clinic. The importance of this pathway in processing DNA damage makes its members potential targets for novel chemotherapeutic agents. However, because the BER process and its main players are remarkably divergent from S. cerevisiae to humans, it is worth keeping these differences in mind if yeast continues to be used as a model or primary system in the screening for potential new human therapeutics.

Citing Articles

TORC2 inhibition triggers yeast chromosome fragmentation through misregulated Base Excision Repair of clustered oxidation events.

Shimada K, Tarashev C, Bregenhorn S, Gerhold C, van Loon B, Roth G Nat Commun. 2024; 15(1):9908.

PMID: 39548071 PMC: 11568337. DOI: 10.1038/s41467-024-54142-z.


DNA damage checkpoint and repair: From the budding yeast to the pathogenic fungus .

Yao S, Feng Y, Zhang Y, Feng J Comput Struct Biotechnol J. 2021; 19:6343-6354.

PMID: 34938410 PMC: 8645783. DOI: 10.1016/j.csbj.2021.11.033.


Dissecting Highly Mutagenic Processing of Complex Clustered DNA Damage in Yeast .

Kozmin S, Eot-Houllier G, Reynaud-Angelin A, Gasparutto D, Sage E Cells. 2021; 10(9).

PMID: 34571958 PMC: 8471780. DOI: 10.3390/cells10092309.


Combining Nanopore and Illumina Sequencing Permits Detailed Analysis of Insertion Mutations and Structural Variations Produced by PEG-Mediated Transformation in .

Thomy J, Sanchez F, Gut M, Cruz F, Alioto T, Piganeau G Cells. 2021; 10(3).

PMID: 33802698 PMC: 8002553. DOI: 10.3390/cells10030664.


Inferring evolutionary dynamics of mutation rates through the lens of mutation spectrum variation.

Carlson J, DeWitt W, Harris K Curr Opin Genet Dev. 2020; 62:50-57.

PMID: 32619789 PMC: 7646088. DOI: 10.1016/j.gde.2020.05.024.